Statistics for Clearside Biomedical (id:6899 CLSD)

Valuation metrics

Market cap

80.73M

Enterprise value

101.20M

Trailing P/E (ttm)

-2.01

Forward P/E

-2.16

PEG ratio

-2.16

Price/Sales (ttm)

10.73

Price/Book (mrq)

-2.81

Enterprise Value/Revenue

13.45

Enterprise Value/EBITDA

-3.94

Overview

Shares outstanding

74.75M

Float

69.12M

Shares short

1.76M

% Held by insiders

0.07%

% Held by institutions

0.23%

Average volume (10 days)

330.62K

Average volume (90 days)

Price summary

52-Week low

0.92

52-Week high

2.12

52-Week change

6.48%

Beta

2.33

50-Day moving average

1.19

200-Day moving average

1.26

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

95.68%

Operating margin

-8,433.33%

Operational effectiveness

Return on assets

-44.05%

Return on equity

204.15%

Income statement

Revenue (ttm)

0.11

Revenue per share (ttm)

0.11

Quarterly revenue growth (yoy)

Gross profit (ttm)

7.87M

EBITDA

-25,660,000.00

Net income to common (ttm)

-33,456,000.00

Diluted EPS (ttm)

-0.50

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

29.36M

Total cash per share (mrq)

0.39

Total debt (mrq)

47.59M

Total Debt/Equity (mrq)

-1.68

Current ratio (mrq)

506.80%

Book value per share (mrq)

-0.38

Cash flow

Cash flow statement

-19,111,000.00

Levered free cash flow (LFCF)

-17,503,250.00